Portal de Periódicos da CAPES

Virology—the path forward

2024; American Society for Microbiology; Volume: 98; Issue: 1 Linguagem: Inglês

10.1128/jvi.01791-23

1098-5514

Angela L. Rasmussen, Gigi Kwik Grönvall, Anice C. Lowen, Felicia Goodrum, James C. Alwine, Kristian G. Andersen, Simon J. Anthony, Joel D. Baines, Arinjay Banerjee, Andrew J. Broadbent, Christopher B. Brooke, Samuel K. Campos, Patrizia Caposio, Arturo Casadevall, Gary C. Chan, Anna R. Cliffe, Donna Collins-McMillen, Nancy Connell, Blossom Damania, Matthew D. Daugherty, Kari Debbink, Terence S. Dermody, Daniel DiMaio, W. Paul Duprex, Michael Emerman, Denise A. Galloway, Robert F. Garry, Stephen A. Goldstein, Alexander L. Greninger, Amy L. Hartman, Brenda G. Hogue, Stacy M. Horner, Peter J. Hotez, Jae U. Jung, Jeremy P. Kamil, Stephanie M. Karst, Lou Laimins, Seema S. Lakdawala, Igor Landais, Michael Letko, Brett D. Lindenbach, Shan‐Lu Liu, Micah A. Luftig, Grant McFadden, Andrew Mehle, Juliet Morrison, Anne Moscona, Elke Mühlberger, Joshua Munger, Karl Münger, Eain A. Murphy, Christopher J. Neufeldt, Janko Nikolich‐Žugich, Christine M. O’Connor, Andrew Pekosz, Sallie R. Permar, Julie K. Pfeiffer, Saskia Popescu, John G. Purdy, Vincent R. Racaniello, Charles M. Rice, Jonathan A. Runstadler, Martin Sapp, Rona S. Scott, Gregory A. Smith, Erin M. Sorrell, Emily Speranza, Daniel N. Streblow, Scott A. Tibbetts, Zsolt Tóth, Koenraad Van Doorslaer, Susan R. Weiss, Elizabeth White, Timothy M. White, Christiane E. Wobus, Michael Worobey, Satoko Yamaoka, Andrew D. Yurochko,

Animal Disease Management and Epidemiology

ABSTRACT In the United States (US), biosafety and biosecurity oversight of research on viruses is being reappraised. Safety in virology research is paramount and oversight frameworks should be reviewed periodically. Changes should be made with care, however, to avoid impeding science that is essential for rapidly reducing and responding to pandemic threats as well as addressing more common challenges caused by infectious diseases. Decades of research uniquely positioned the US to be able to respond to the COVID-19 crisis with astounding speed, delivering life-saving vaccines within a year of identifying the virus. We should embolden and empower this strength, which is a vital part of protecting the health, economy, and security of US citizens. Herein, we offer our perspectives on priorities for revised rules governing virology research in the US.